Keith Hinton
Stock Analyst at Freedom Capital Markets
(1.94)
# 3,238
Out of 4,517 analysts
6
Total ratings
75%
Success rate
5.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Keith Hinton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Initiated Coverage: Hold | $81 | $81.79 | -0.97% | 1 | Jun 30, 2026 | |
| INSP Inspire Medical Systems | Initiated Coverage: Buy | $62 | $51.54 | +20.29% | 1 | Jun 30, 2026 | |
| ENOV Enovis | Initiated Coverage: Buy | $45 | $28.07 | +60.31% | 1 | Dec 16, 2025 | |
| GMED Globus Medical | Initiated Coverage: Hold | $87 | $80.91 | +7.53% | 1 | Dec 16, 2025 | |
| ATEC Alphatec Holdings | Initiated Coverage: Buy | $25 | $9.27 | +169.69% | 1 | Dec 10, 2025 | |
| VCYT Veracyte | Initiated Coverage: Buy | $45 | $59.22 | -24.01% | 1 | Oct 16, 2025 |
LivaNova
Jun 30, 2026
Initiated Coverage: Hold
Price Target: $81
Current: $81.79
Upside: -0.97%
Inspire Medical Systems
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $62
Current: $51.54
Upside: +20.29%
Enovis
Dec 16, 2025
Initiated Coverage: Buy
Price Target: $45
Current: $28.07
Upside: +60.31%
Globus Medical
Dec 16, 2025
Initiated Coverage: Hold
Price Target: $87
Current: $80.91
Upside: +7.53%
Alphatec Holdings
Dec 10, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $9.27
Upside: +169.69%
Veracyte
Oct 16, 2025
Initiated Coverage: Buy
Price Target: $45
Current: $59.22
Upside: -24.01%